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C-low-threshold mechanoreceptors (C-LTMRs) are
sensory neurons that, beyond conveying pleasant
touch, modulate nociceptive transmission within
the spinal cord. However, pain alleviation by
C-LTMRs remains poorly understood. Here, we
show that the C-LTMR-derived TAFA4 chemokine in-
duces a reinforcement of inhibitory synaptic trans-
mission within spinal networks, which consequently
depresses local excitatory synapses and impairs
synaptic transmission from high-threshold C-fibers.
In animals with inflammation induced by Freund’s
complete adjuvant, TAFA4 decreases the noxious
stimulus-induced neuronal responses recorded
in vivo and alleviates mechanical pain. Both effects
are blocked by antagonists of GABAergic trans-
mission. Furthermore, TAFA4 promotes microglial
retraction in inflammation and increases the number
of inhibitory synapses on lamina IIi somata. Alto-
gether, these results demonstrate GABAergic inter-
neurons to be the first integration relay for C-LTMRs
and highlight a tight interplay between sensory neu-
rons, microglial cells, and spinal interneurons, which
fine-tunes inhibitory activity and nociceptive trans-
mission in pathological conditions.INTRODUCTION
Acute pain is an alarm signal allowing behavioral adaptation in
response to potentially harmful stimuli. However, in pathological
conditions, acute pain can turn into chronic maladaptive pain,
which results from central sensitization of dorsal spinal networks
(Latremoliere and Woolf, 2009; Woolf, 2011). A large body of
work has shown the key role played by the disinhibition of dorsal
spinal networks in chronic pain pathologies (Guo and Hu, 2014;
Lin et al., 1996; Taylor, 2009). Specifically, nerve injury or inflam-
mation can lead to a loss of GABAergic inhibition (Moore et al.,
2002; Laffray et al., 2012; Zhang et al., 2013). For instance, mi-2886 Cell Reports 22, 2886–2897, March 13, 2018 ª 2018 The Autho
This is an open access article under the CC BY license (http://creativecroglial cells are known to regulate the strength of inhibitory
synapses through an attenuation of chloride gradients (Coull
et al., 2005). Microglia also modulate inhibitory transmission by
the release of proinflammatory cytokines (Kawasaki et al.,
2008). Thus, many forms of pathological pain may result from
an impairment of the fragile interplay between inhibitory synap-
ses and the surrounding glial cells, making its alleviation very
challenging.
Since thepioneeringworkofMelzackandWall (1965), inhibitory
networks in the spinal cord have been thought to be tightly driven
by low-threshold peripheral inputs (Daniele and MacDermott,
2009; Takazawa and MacDermott, 2010). In pathological pain,
this drive is thought to be deficient (Leitner et al., 2013; Lu et al.,
2013;Sdrullaet al., 2015), thus leading toaweakeningof inhibitory
activity, which may, in turn, reinforce nociceptive transmission.
Among the low-threshold inputs, recent attention has been paid
to C-low-threshold mechanoreceptors (C-LTMRs) in modulating
pain transmission (Delfini et al., 2013; Seal et al., 2009). These
fibers, whose cell bodies are located within dorsal root ganglia
(DRG), innervate the hairy skin and project specifically toward
the innermost layer of lamina II (lamina IIi) of the spinal cord to syn-
apse with second-order neurons (Li et al., 2011; Lumpkin et al.,
2010). Previous studieshavedemonstrated thatC-LTMRsconsti-
tute a unique neuronal population among the DRG neurons, spe-
cifically expressing vesicular glutamate transporter 3 (VGLUT3;
Seal et al., 2009) and TAFA4, a chemokine-like secreted protein
(Delfini et al., 2013). In a persistent pain model, TAFA4 null mice
developed mechanical hypersensitivity, which was reversed by
an intrathecal injection of TAFA4 (Delfini et al., 2013). Althoughpo-
tassium channels were identified as a putative target of TAFA4,
the mechanisms underlying the control of sensori-nociceptive
integration by TAFA4 remains poorly understood. Surprisingly,
TAFA4was recently identified as a ligand of formyl peptide recep-
tor 1 (FPR1) that is expressed both onmacrophages (Wang et al.,
2015), where it promotes cell migration and phagocytosis, and on
microglial cells (Gavins, 2010).
In this study, we used the C-LTMRs’ restricted expression
of TAFA4 to investigate the contribution of these neurons to
the control of nociceptive information transmission. We demon-
strate by whole-cell recordings of lamina IIi neurons that appli-
cation of TAFA4 induces an increase in inhibitory synaptic activ-
ity through presynaptic mechanisms, which, in turn, dampensr(s).
commons.org/licenses/by/4.0/).
A1
A3
B1 B2
B3 B2
A4
A2 Figure 1. Effects of TAFA4 on Spontaneous
Synaptic Activity of Lamina IIi Neurons
(A and B) Shown in (A1) and (B1): representative
current traces of EPSCs (A1) and IPSCs (B1) re-
corded from lamina IIi neuron in control, after 40min
of TAFA4 superfusion, and after washout. (A2 and
B2) Cumulative distribution of inter-EPSC (A2) and
IPSC (B2) intervals corresponding to traces in (A1)
and (B1) (control versus TAFA4: p < 0.05, Kolmo-
gorov-Smirnov test). (A3 and A4) Quantification of
EPSC mean frequency (A3) and amplitude (A4) in
control (n = 16), following 20 and 40 min TAFA4
superfusion (n = 16), and after washout (n = 7). (B3
andB4)Quantification of IPSCmean frequency (B3)
and IPSCamplitude (B4) in control (n =14), following
20-min and 40-min TAFA4 superfusion (n = 14), and
after washout (n = 8).
Data are represented as mean ± SEM. *p < 0.05,
repeated-measures ANOVA for (A3), (A4), (B3),
and (B4).excitatory synaptic transmission and impairs transmission be-
tween nociceptive fibers and interneurons. In CFA (complete
Freund’s adjuvant)-inflamed animals, TAFA4 induces a decrease
in the neuronal activity evoked by noxious stimulation of the
hindpaw that is dependent on GABAergic transmission integrity.
Furthermore, intrathecal administration of TAFA4 provides
analgesic effects that are also blocked by GABA receptor
antagonists, so GABAergic interneurons are the first relay
in the integration of information transmitted by C-LTMRs.
Interestingly, ultrastructural studies revealed close interaction
between TAFA4-expressing primary afferent fibers (PAFs) and
GABAergic terminals in lamina IIi. By investigating the role ofCell Remicroglia in TAFA4-induced inhibition,
we demonstrate that TAFA4 loses its ef-
fect on spontaneous synaptic activity
when the activation of microglial cells is
prevented. TAFA4 also induces micro-
glial retraction, which enables the specific
restoration of inhibitory synapses on
lamina IIi neurons, thus promoting the
reinforcement of inhibitory transmission.
Altogether, these results highlight a close
interplay between sensory neurons, mi-
croglial cells, and local spinal neurons,
leading to the fine-tuning of inhibitory
activity and nociceptive transmission in
pathological conditions.
RESULTS
TAFA4Modulates Spontaneous and
Evoked Synaptic Transmission in
Dorsal Spinal Cord through
Presynaptic Mechanisms
To gain further understanding of the ef-
fects of TAFA4 on synaptic transmission
within the spinal cord, we recorded spon-taneous synaptic events in Rexed lamina IIi neurons usingwhole-
cell patch-clamp recordings (Figure 1A1, top) and assessed the
effects of TAFA4 superfusion on the frequency and amplitude
of these events. Bath application of TAFA4 (20 nM) induced a sig-
nificant decrease in spontaneous excitatory post-synaptic cur-
rent (EPSC) event frequency (Figure 1A1, middle), as indicated
by the shift in the interval cumulative distribution curve toward
the left (Figure 1A2, same cell as in Figure 1A1; n = 10 out
of 16). This effect was long lasting, as only 2 cells out of 7 showed
a significant recovery upon washout. Although this decrease
could be observed 20 min after the onset of TAFA4 superfusion,
it became significant only after 40 min (Figure 1A3). All in all, theports 22, 2886–2897, March 13, 2018 2887
average frequency of EPSCswas 59.5% lower in the presence of
TAFA4 than in control conditions (control: 0.94 ± 0.29 Hz, n = 16;
TAFA4, 20 min: 0.540 ± 0.16 Hz, n = 16; TAFA4, 40 min: 0.382 ±
0.08 Hz, n = 16; wash: 0.587 ± 0.19 Hz, n = 7; p < 0.05). The dis-
tribution of EPSC decay was similar in control and TAFA4 condi-
tions (Figure S1A, n = 16). Strikingly, the amplitude of EPSCswas
not affected by TAFA4 superfusion (Figure 1A4; control: 30.83 ±
2.88 pA; TAFA4, 20 min: 27.12 ± 3.2 pA; TAFA4, 40 min:
27.46 ± 4.54 pA; wash: 29.98 ± 3.0 pA), suggesting the involve-
ment of a pre-synaptic mechanism.
By contrast, the frequency of spontaneous inhibitory post-
synaptic currents (IPSCs) recorded using a chloride-enriched
solution (Figure 1B1, top) exhibited a dramatic increase following
TAFA4 superfusion, as indicated by the shift toward the right of
the inter-event interval cumulative distribution curve (Figures
1B1, middle, and 1B2; n = 10 out of 14; Figures 1B1 and 1B2
are of the same cell). This increase was reversed upon rinsing
in 3 cells out of 8. The distribution of IPSC decay was similar in
control and TAFA4 conditions (Figure S1B, n = 8). On average,
after 40 min of application, TAFA4 induced a 94% increase in
IPSC frequency (Figure 1B3; control: 0.14 ± 0.026 Hz, n = 14;
TAFA4, 20 min: 0.20 ± 0.03 Hz, n = 14; TAFA4, 40 min: 0.27 ±
0.06 Hz, n = 14; wash: 0.16 ± 0.02 Hz, n = 8; p < 0.05) without
affecting IPSC average amplitude (Figure 1B4; control: 35.00 ±
5.51 pA; TAFA4, 20 min: 31.98 ± 3.77 pA; TAFA4, 40 min:
34.16 ± 3.19 pA; wash: 41.90 ± 5.91 pA), thereby reinforcing
the hypothesis of a pre-synaptic action of TAFA4.
To show that the effects of TAFA4 on EPSC and IPSC fre-
quency were mediated by pre-synaptic mechanisms, we moni-
tored the frequency of miniature synaptic events (mEPSC and
mIPSC) in the presence of tetrodotoxin (TTX) to block action
potential propagation in control, following 40min of TAFA4 appli-
cation and after washout (Figure 2A1). In the presence of TTX,
TAFA4 induced a significant decrease in mEPSC frequency in
6 out of 14 neurons (Figure 2A2). On average, mEPSC frequency
was 32% lower following TAFA4 exposure than in control condi-
tions (Figure 2A3; control: 0.35 ± 0.091 Hz; TAFA4, 40 min:
0.24 ± 0.06 Hz; p < 0.05). On the other hand, TAFA4 induced a
significant increase in mIPSC frequency recorded in the pres-
ence of TTX in 6 cells out of 8 (Figures 2B1 and 2B2). On average,
the frequency of mIPSCs was 169% higher under TAFA4 super-
fusion than in control conditions (Figure 2B3; control: 0.09 ±
0.01 Hz; TAFA4, 40 min: 0.23 ± 0.04 Hz; wash: 0.18 ± 0.07 Hz;
p < 0.05). Under TTX superfusion, TAFA4 had no effect on
mEPSC or mIPSC amplitude (data not shown). Therefore, the ef-
fects of TAFA4 on EPSC and IPSC frequencies were preserved in
the presence of TTX, indicating a presynaptic regulation of syn-
aptic transmission.
To investigate whether TAFA4 also presynaptically modulates
synaptic transmission between high-threshold PAF and lamina IIi
neurons, we recorded in lamina IIi the synaptic responses
evoked by paired maximal stimulations of attached dorsal roots
(Figures 2C1 and 2C2). Following TAFA4 application, the ampli-
tude of the first evoked EPSC was greatly reduced (Figure 2C3;
n = 18; average: 35%; control: 347 ± 94 pA; TAFA4: 225 ±
60 pA; p < 0.05), while the paired pulse ratio (PPR) of the synaptic
responses was significantly increased (Figure 2C4; n = 18;
average: +28.8%; control: 0.81 ± 0.10; TAFA4: 1.046 ± 0.12),2888 Cell Reports 22, 2886–2897, March 13, 2018Thus, TAFA4 impairs synaptic transmission between PAFs and
lamina IIi neurons by decreasing neurotransmitter release from
high-threshold presynaptic sensory fibers.
TAFA4 Modulates Excitatory Transmission through
GABA Receptors
The decrease in EPSC frequency and synaptic transmission
between primary fibers and lamina IIi neurons could result from
an increased inhibitory tonus exerted on excitatory neurons
and primary fibers. To test this hypothesis, we recorded EPSC
frequency while blocking inhibitory transmission (Figure 3A1)
with CGP55845A (CGP) and bicuculline (antagonists of GABAB
and GABAA receptors, respectively) and with strychnine (antag-
onist of glycinergic receptors). We found no difference in the
average EPSC frequency between control and TAFA4 conditions
(Figure 3A2; n = 10; control: 2.80 ± 1.04 Hz; TAFA4: 2.16 ±
0.61 Hz), indicating that the effect of TAFA4 on EPSC frequency
is dependent upon inhibitory transmission. Of note, TAFA4 had
no effect on mEPSC frequency when inhibitory transmission
was blocked (Figure S2). More specifically, by blocking solely
GABAergic or glycinergic transmission, we found that TAFA4
no longer modulated EPSC frequency when GABAergic trans-
mission alone was blocked (Figure 3A3; n = 11; control: 0.63 ±
0.32 Hz; TAFA4: 0.80 ± 0.42 Hz), whereas a decrease in EPSC
frequency was still observed upon TAFA4 application when
only glycinergic transmission was blocked (Figure 3A4; n = 17;
control: 0.50 ± 0.15 Hz; TAFA4: 0.35 ± 0.09 Hz; p < 0.05).
Similarly, the addition of CGP and bicuculline to the perfusion
medium blocked the effects of TAFA4 on the amplitude (Figures
3C1 and 3C2; n = 15; average: 5.3%; control: 431 ± 112 pA;
TAFA4: 408 ± 117 pA; compare with Figure 2C3) and the PPR
(Figures 3C1 and 3C3; n = 15; average: 1.4%; control: 0.86 ±
0.08; TAFA4: 0.86 ± 0.12; compare with Figure 2C4) of dorsal-
root-evoked synaptic responses. Thus, the TAFA4-mediated
decrease in EPSC frequency and in synaptic transmission
between PAFs and spinal interneurons is indirect and mainly
mediated by a modulation of GABAergic transmission by
TAFA4.
C-LTMRsMakeDirect Contact onto GABAergic Neurons
There is, therefore, a close functional interaction between TAFA4
and inhibitory GABAergic transmission. As C-LTMRs are the only
source of TAFA4 within the spinal cord (Delfini et al., 2013), we
investigated whether direct contact between C-LTMR fibers
and GABAergic neurons could be observed in the spinal cord.
We used TAFA4Venus knockinmice (Delfini et al., 2013) to perform
multiple immunolabeling ultrastructural experiments and used
GFP and VGLUT3 as markers of C-LTMRs and IB4 as a marker
of non-peptidergic PAFs. Venus was specifically co-expressed
with VGLUT3 in a population of non-peptidergic PAFs but was
not present in IB4-immunolabeled fibers (Figure 4A). The central
terminal of Venus-positive fibers formed typical type 1a glomeruli
with an electron-dense C bouton filled by small agranular synap-
tic vesicles surrounded by numerous dendrites (indicated with
a ‘‘d’’ in Figure 4A), including a presynaptic-vesicle-containing
dendrite (V1) and a few peripheral axons (V2; data not shown;
see also Figure S5). Venus-positive fibers mostly formed con-
tacts with GABA-IR presynaptic vesicle-containing dendrites
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Figure 2. Presynaptic Action of TAFA4 on Spontaneous and Evoked Synaptic Activity
(A and B) Shown in (A1) and (B1): representative current traces of miniature EPSCs (A1) and IPSCs (B1) recorded from a lamina IIi neuron under TTX in the control
condition, following 40 min of TAFA4 superfusion, and after wash. (A2 and B2) Cumulative distribution of inter-mEPSC (A2) and mIPSC (B2) intervals corre-
sponding to traces in (A1) and (B1) (control versus TAFA4: p < 0.05, Kolmogorov-Smirnov test). (A3 and B3) Quantifications of lamina IIi neuron mEPSC (A3) and
mIPSC (B3) mean frequencies (mEPSC: n = 14; mIPSC: n = 8) following 40-min TAFA4 superfusion (mEPSC: n = 14; mIPSC: n = 8) and after washout (mEPSC:
n = 14; mIPSC: n = 8).
(C) Shown in (C1): schematic representation of experimental procedure used to record evoked EPSCs from lamina IIi neurons. (C2) Normalized representative
traces of evoked EPSCs obtained before and after bath application of TAFA4. (C3 andC4) Quantification of the amplitude of the first evoked EPSC (C3; n = 18) and
PPR of synaptic responses in control and TAFA4 conditions (C4; n = 18). Decreases in synaptic responses and increases in PPR are presented in red, while
increases in synaptic response and decreases in PPR are represented in green.
*p < 0.05, one-way repeated-measures ANOVA for (A3) and (B3), Wilcoxon signed-rank test for (C3), and Student’s paired t test for (C4). ns, not significant.(V1 in Figure 4B). After quantitative analysis of 150 GFP-IR-GIa
(N = 3mice), we observed that all V1wereGABA immunolabeled,
only a minority of V2 were GABA-IR, while no plain dendrites
(d in Figure 4C) were GABA-IR. These data showed a net pre-
dominance of synaptic contacts between GFP-positive fibers
and GABA-IR V1 (95.9%; Figure 4D) rather than GABA-IR V2
(4.1%; Figure 4D). Hence, C-LTMR fibers establish direct synap-
tic contact with GABAergic interneurons within lamina IIi.
TAFA4 Alleviates CFA-Induced Pain through
Reinforcement of Inhibitions within Spinal Cord
Our patch-clamp experiments demonstrated that TAFA4 in-
creases inhibitory transmission within the spinal cord, which,
in turn, depresses excitatory transmission, including transmis-
sion between high-threshold PAFs and spinal interneurons. To
assess whether this mechanism may account for the antinoci-
ceptive effects of TAFA4, we used an inflammatory pain model
consisting of an injection of CFA in the rear paw.Four days after CFA injection, we performed whole-cell patch-
clamp recordings on spinal cord slices incubated for 40 min in
TAFA4 or in artificial cerebro spinal fluid (aCSF). Slices incubated
in TAFA4 exhibited lower average EPSC frequency (Figure S3A)
and higher average IPSC frequency (Figure S3B) than slices
incubated in aCSF. The average PPR of synaptic responses
evoked by dorsal root stimulation was also higher in slices incu-
bated in TAFA4 (Figure S3C). Altogether, these data suggest that
the mechanisms identified in spinal slices of naive animals are
mostly conserved in slices of CFA animals.
We next used extracellular in vivo recordings of superficial spi-
nal cord neurons to assess the effects of TAFA4 on the neuronal
discharge evoked by Von Frey hair noxious stimulation of the
hindpaw. In naive animals, intraspinal injection of TAFA4 or
aCSF had no effect on the average discharge frequency of neu-
rons during hindpaw stimulation (Figures S4A and S4B). By
contrast, in CFA-inflamed animals, TAFA4 induced a significant
decrease in the neuronal discharge following a noxious stimulusCell Reports 22, 2886–2897, March 13, 2018 2889
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Figure 3. The Effect of TAFA4 on Excitatory Transmission Is Mediated by Inhibitory Transmission
(A) Shown in (A1): representative traces of EPSCs recorded with antagonists of GABAA (bicuculline), GABAB (CGP), and glycinergic receptors (Strychnine), before
and after 40 min of exogenous application of TAFA4. (A2–A4) Histogram comparing EPSC frequency before and after application of TAFA4 in the presence of
bicuculline, CGP, and strychnine (A2; n = 10); bicuculline and CGP only (A3; n = 11); or strychnine only (A4; n = 17).
(B) Shown in (B1): normalized representative traces of evoked excitatory synaptic responses obtained before and after bath application of TAFA4 in the presence
of bicuculline and CGP. (B2 and B3) Quantification of amplitude of the first evoked EPSC (B2; n = 15) and PPR of synaptic responses in the control and TAFA4
conditions (B3; n = 15). Decreases in synaptic responses and increases in PPR are presented in red, while increases in synaptic response and decreases in PPR
are represented in green.
Data are represented as mean ± SEM. *p < 0.05, paired Student’s t test for (A2)–(A4), Wilcoxon signed-rank test for (B2), and Student’s paired t test for (B3). ns,
not significant.(Figures 5A1 and 5A2; N = 5; control: 152.39 ± 16.08 Hz; TAFA4,
40 min: 109.55 ± 29.50 Hz; p < 0.05) that was not observed when
aCSF only was injected (Figures 5A1 and 5A2; N = 5; control:
93.70 ± 22.89 Hz; TAFA4, 40 min: 128.41 ± 31.59 Hz). Further-
more, this decrease was abolished when TAFA4was co-injected
with blockers of GABAergic synaptic transmission (Figures 5B1
and 5B2; N = 5; control: 70.33 ± 5.06 Hz; TAFA4, 40 min:
76.36 ± 4.47 Hz). Taken together, these results demonstrate
that TAFA4 impaired the integration of noxious input through
GABAergic transmission in inflammatory conditions.
Finally, we investigated whether mechanical hypersensitivity
developed by CFA-inflamed animals could be reversed with an
intrathecal injection of TAFA4 and whether this reversal was
dependent upon GABAergic transmission. Von Frey tests per-
formed 4 days after CFA injection showed that inflamed animals2890 Cell Reports 22, 2886–2897, March 13, 2018exhibited a dramatic decrease in paw withdrawal threshold that
could be partially reversed within 1 hr following an intrathecal in-
jection of TAFA4 (Figure 5C; N = 16; control: 1.12 ± 0.13 g; CFA:
0.09 ± 0.03 g; CFA-TAFA4: 0.50 ± 0.06 g; p < 0.05). However, no
reversal of pain threshold was observed when TAFA4 was co-
injected with antagonists of the GABAA and GABAB receptors
bicuculline and phaclofen, respectively (Figure 5C; N = 12;
0.057 ± 0.006 g), indicating that the antinociceptive effect of
TAFA4 is mediated by GABAergic transmission.
TAFA4 Induces Microglial Retraction in CFA Animals
A recent study (Wang et al., 2015) demonstrated that TAFA4
binds FPR1 expressed on macrophages and microglial cells.
To assess whether microglia are involved in the modulation of
inhibitory transmission mediated by TAFA4, we first recorded
C D
BA Figure 4. Ultrastructural Localization of
TAFA4-Expressing C-LTMRs and Relationship
with Lamina IIi GABA-IR Interneurons
(A) Two immunoreactive type Ia non-peptidergic
glomeruli (GIa) in lamina IIi. The GIa at top in the figure
is double-labeled for GFP (10-nm gold particles; in the
top left insert, this is indicated with an arrow) and
VGLUT3 (30-nm gold particles; in the top left insert,
this is indicated with a double arrowhead), while the
GIa at bottom is labeled only for IB4 (20-nm gold
particles; in the bottom left insert, this is indicated with
arrowheads). GFP and VGLUT3 are scattered over the
GIa central terminal, while IB4 is exclusively localized
over the GIa plasma membrane. Scale bars, 300 nm;
20 nm in the inserts.
(B) A GFP + VGLUT3-immunoreactive GIa is sur-
rounded by different unlabeled dendrites (d) and
makes a synapse with a GABA-immunolabeled
vesicle-containing dendrite (V1 [indicated as v1], ar-
rowheads). GFP (10-nm gold particles) and VGLUT3
(30-nm gold particles) are scattered over the GIa
central terminal (left insert; indicated with an arrow
and a double arrowhead, respectively). GABA (20-nm
gold particles) is distributed in the intracellular aspect
of the V1 (indicated with an arrowhead in the right
insert). Scale bars: 300 nm; 20 nm in inserts.
(C) Histogram showing the number of synaptic
contacts between GFP-immunolabeled GIa and the
surrounding neuronal profiles (V1, vesicle-containing dendrites; D, plain dendrites; V2, peripheral axons) engaged in the glomerular configuration (black bars
indicate number of synaptic contacts between GFP-IR GIa/GABA-positive V1 and V2 profiles; gray bars indicate number of synaptic contacts between GFP-IR
GIa/GABA-negative D and V2 profiles). Quantitative analysis was performed by observing randomly selected images of GFP-immunolabeled GIa (n = 150 from
N = 3 mice) at a magnification of 40,0003 to precisely identify the synaptic contacts.
(D) Pie chart showing the percentage of synaptic contacts betweenGFP+ GIa/GABA-IR V1 (95.9%) and GFP+ GIa/GABA-IR V2 (4.1%). Quantitative analysis was
performed by observing the same randomly selected images of GFP-immunolabeled GIa (n = 150 from N = 3 mice) used for the analysis described in (C).EPSCs and IPSCs in spinal cord slices pre-incubated with min-
ocycline, which inhibits microglial activation. After TAFA4 super-
fusion, no significant changes were detected either in EPSC fre-
quency (Figures 6A1 and 6A2; n = 10; control: 0.38 ± 0.15 Hz;
TAFA4: 0.35 ± 0.18 Hz) or IPSC frequency (Figures 6B1 and
6B2; n = 10; control: 0.26 ± 0.10 Hz; TAFA4: 0.12 ± 0.04 Hz)
when the activation of microglia was inhibited. Thus, microglia
are required for TAFA4 to induce a shift in inhibitory/excitatory
balance (compare Figure 1A3 with Figure 6A2 and Figure 1B3
with Figure 6B2).
We then characterized microglial reactivity in the dorsal horn
of inflamed animals treated or not treated with TAFA4 by using
immunohistochemistry to quantify the surface labeled by the
ionized calcium binding adaptor molecule 1 (Iba1; Figure 6C1).
CFA injection induced a significant increase in the surface
labeled by Iba1 that was partially reversed by the intrathecal in-
jection of TAFA4 (Figure 6C2; N = 3; naive: 1.55 ± 0.31%; CFA:
6.99 ± 0.27%; CFA + TAFA4: 5.39 ± 0.27%; p < 0.05), showing
that TAFA4 reduces microglial activation. Strikingly, our electron
microscopy (EM) data suggest that putative microglial cells may
contact GABAergic V1 profiles surrounding C-LTMRs endings
(Figure S5). To investigate whether the interaction between
microglial cells and inhibitory synapses is altered by TAFA4,
we performed immunohistochemistry to label gephyrin, a spe-
cific post-synaptic marker of inhibitory synapses, and Iba1 and
quantified the number of inhibitory synapses in close apposition
with microglial cells. Strikingly, the spreading of microglia in thedorsal horn of CFA animals was accompanied by an increase in
the number of inhibitory synapses in contact with microglial cells
(yellow dots). Furthermore, this increase was partially reversed
following intrathecal TAFA4 injection (Figures 6D1 and 6D2;
N = 3; control: 1.76 ± 0.40%; CFA: 5.31 ± 0.20%; CFA +
TAFA4: 3.52 ± 0.43%; p < 0.05). Altogether, our data provide ev-
idence that TAFA4 reverses the increased interaction between
inhibitory synapses andmicroglial processes observed in inflam-
matory conditions. Furthermore, by quantifying the surface of
neuronal soma (revealed by immunodetection of NeuN) occu-
pied by inhibitory synapses (labeled by gephyrin; Figure 7A1),
we found that CFA inflammation induced a reduction in the
soma surface co-labeled with gephyrin compared to naive ani-
mals, suggesting a disruption of inhibitory synapses in CFA ani-
mals. In TAFA4-treated inflamed mice, the surface of neuronal
somata occupied by inhibitory synapses was recovered and
similar to the control level, indicating a restoration of inhibitory
contacts on lamina IIi somata (Figure 7A2; 315 neurons from
N = 3 animals; control: 4.96 ± 0.50%; CFA: 3.66 ± 0.33%;
CFA + TAFA4: 5.26 ± 0.52%; p < 0.05). Remarkably, similar ex-
periments quantifying the number of excitatory synapses labeled
with the post-synaptic excitatory synapse marker Homer (Fig-
ure 7B1) revealed no difference in the neuron soma area covered
by excitatory synapses between naive animals, CFA-inflamed
animals, and CFA-inflamed animals treated with TAFA4 (Fig-
ure 7B2; 315 neurons from N = 3 animals; control: 12.43 ±
1.75%; CFA: 12.48 ± 1.05%; CFA + TAFA4: 13.29 ± 1.04%).Cell Reports 22, 2886–2897, March 13, 2018 2891
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Figure 5. TAFA4 Decreases Neuronal Discharge Elicited by Noxious Stimulation in CFA Animals
(A) Shown in (A1): representative traces of extracellular in vivo recordings obtained from neurons located in superficial laminae activated by a noxious mechanical
stimulus (Von Frey hair filament, 15 g) in CFA animals after an infusion of either aCSF or TAFA4. (A2) Quantification of action potential mean frequencymeasured in
control condition (5 min) and every 10 min after injection of aCSF (N = 5) or TAFA4 (N = 5) until 60 min.
(B) Shown in (B1): representative neuronal responses to a mechanical noxious stimulus recorded with antagonists of GABAA and GABAB receptors (bicuculline
and CGP) co-injected with either aCSF or TAFA4. (B2) Quantification of action potential frequency before and after intra-spinal injection of aCSF or TAFA4 in the
presence of GABAA and GABAB antagonists (N = 5).
(C) Histogram ofmechanical sensitivity assessedwith Von Frey hairs in naive (N = 16) or CFA (N = 16) animals intrathecally injectedwith TAFA4 (N = 16) and TAFA4
with phaclofen and bicuculline (N = 12).
Data are represented as mean ± SEM. *p < 0.05; ***p < 0.001, two-way repeated-measures ANOVA followed by Newman-Keuls test for (A2) and (B2) and
Student’s t test for (C).Altogether, our experiments highlight a tight interplay be-
tween the C-LTMR-derived chemokine TAFA4, microglial cells,
and inhibitory synapses. In CFA-inflamed animals, microglial
spreading promotes the synaptic stripping of inhibitory synap-
ses, resulting in a weakened inhibitory tonus within spinal cord
nociceptive networks. This weakened tone, in turn, reinforces
both excitatory influences from local interneurons and excitatory
transmission between high-threshold nociceptive fibers and
lamina IIi networks (Figure 7C1). C-LTMR-derived TAFA4 che-2892 Cell Reports 22, 2886–2897, March 13, 2018mokine is able to partially reverse this microglial spreading, pro-
moting the re-innervation of lamina IIi somata by inhibitory syn-
apses and a reinforcement of inhibitory tonus that attenuates
pain transmission within the spinal cord (Figure 7C2).
DISCUSSION
Recent findings have highlighted the role of C-LTMRs in fine-
tuning pain transmission within spinal cord networks (Delfini
A1 B1
A2 B2
C1 D1
C2 D2
Figure 6. The Effect of TAFA4 IsMediated by
Microglia, which Undergo Process Retrac-
tion upon TAFA4 Application
(A) Shown in (A1): representative current traces of
EPSCs recorded in lamina IIi neurons before and
after TAFA4 superfusion, in slices incubated within
minocycline 1.5 hr before recording. (A2) Com-
parison of EPSCmean frequencies recorded in the
control condition (minocycline; n = 10) and TAFA4
condition (minocycline + TAFA4; n = 10).
(B) Shown in (B1): representative recording of
IPSCs obtained from lamina IIi neurons recorded in
slices incubated with minocycline, before and
40 min after TAFA superfusion. (B2) Quantification
of IPSC mean frequencies before and after su-
perfusion with TAFA4 in minocycline-incubated
slices (n = 10).
(C) Shown in (C1): immunohistochemistry for Iba1
in lumbar dorsal spinal cord sections (top; scale
bar: 60 mm) and in lamina IIi (bottom; scale bar:
20 mm) in control, CFA-inflamed, and CFA-in-
flamed with intrathecal TAFA4 animals. (C2)
Quantification of the lamina II surface labeled
with Iba1 (percentage of total surface of confocal
acquisition) in control, inflamed, and TAFA4-in-
jected inflamed animals (N = 3 each).
(D) Shown in (D1): immunohistochemistry for Iba1
(red) and gephyrin (green) in lumbar spinal cord
section (left panel, CFA mouse) and 3D recon-
struction of immunostaining (right panel) allowing
the quantification of colocalization between inhib-
itory synapses and microglial cells (yellow dots).
(D2) Quantification of colocalization between ge-
phyrin and Iba1 within lamina II in naive, inflamed,
and TAFA4-injected animals (N = 3 each).
Data are represented as mean ± SEM. **p < 0.01;
***p < 0.001, Student’s paired t test for (A2) and
(B2) and one-way ANOVA for (C2) and (D2).et al., 2013: Seal et al., 2009). However, the microcircuits
involved in this modulation remain poorly understood. Here,
we report that C-LTMRs directly contact GABAergic interneu-
rons in Rexed lamina IIi of the spinal cord. We demonstrate
that C-LTMR-derived chemokine TAFA4 increases synaptic
inhibitory tone in the spinal cord, which, in turn, decreases
spontaneous excitatory transmission through the recruitment
of GABA receptors and weakens the transmission between
PAFs and spinal interneurons, thus resulting in pain alleviation.
Finally, we demonstrate that TAFA4 reverses CFA-induced mi-
croglial extension and promotes an increase in the density of
inhibitory synapses on lamina IIi neurons. Altogether, our re-
sults suggest that C-LTMRs promote the retraction of micro-
glial processes by releasing TAFA4 in the vicinity of inhibitory
neurons, thus enabling the restoration of inhibitory synapses
within lamina IIi.Cell ReLow-Threshold Fibers and
Nociceptive Pathways
The integration of multiple sensory mo-
dalities within the dorsal spinal cord may
create interferences and crosstalk be-
tween these modalities and alter thetransmission of sensory stimuli (Craig and Bushnell, 1994; Mack-
enzie et al., 1975; Yarnitsky and Ochoa, 1990).
For instance, in pathological pain, low-threshold fibers
involved in touch transmission elicit pain by activating superficial
dorsal horn networks dedicated to the integration of noxious
stimuli (Baba et al., 2003; Daniele andMacDermott, 2009; Mirau-
court et al., 2007). On the contrary, low-frequency stimulation of
low-threshold fibers (Ab) may alleviate pain by inducing synaptic
depression in substantia gelatinosa neurons (Sdrulla et al., 2015).
Although recent studies have deciphered neuronal microcircuits
through which touch neurons may alleviate pain transmission
(Duan et al., 2014; Lu et al., 2013), the spinal circuitry underlying
this alleviation remains poorly understood. In our study, we
demonstrate that C-LTMRs contact GABAergic interneurons.
Given the findings of Lu and Perl (2005), who demonstrated
that islet cells receive non-noxious C-fiber inputs, and ofports 22, 2886–2897, March 13, 2018 2893
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Figure 7. Restoration of Inhibitory Contacts
on Dorsal Spinal Cord Neurons by TAFA4
(A1 and B1) High-magnification images of a lamina
IIi neuronal soma immunolabeled for NeuN and
surrounding inhibitory (A1, labeled with gephyrin)
and excitatory (B1, labeled with Homer) synapses
in control, CFA, and TAFA4-injected CFA animals.
(A2 and B2) Quantifications of neuronal soma
surface occupied by (A2) gephyrin or (B2) Homer in
control, CFA, and CFA TAFA4-injected (n = 315
neurons from N = 3 animals each) animals. Scale
bars, 10 mm.
(C) Schematic representation of the proposed
mechanism of action of TAFA4. (C1) In the in-
flammatory condition, activated microglia displace
inhibitory synapses from neuronal soma, leading to
an increase in excitatory transmission and, thus, a
CFA-induced hypersensitivity. (C2) By inducing a
reduction inmicroglial spreading, TAFA4 promotes
the partial restoration of inhibitory transmission.
Data are represented as mean ± SEM. *p < 0.05,
one-way ANOVA for (C2) and (D2).previous studies showing that GABA+ V1 profiles in the
GIa configuration belong to islet cells (Bardoni et al., 2007;
Ribeiro-da-Silva, 2004), we propose that C-LTMRs synapse
onto islet cells within lamina IIi, thus providing a direct pathway
between low-threshold fibers and GABAergic neurons involved
in the modulation of noxious stimuli transmission.
The Effects of TAFA4 Are Mediated through GABAergic
Transmission
Many inhibitory neurons in lamina II exhibit both GABA and
glycine immunoreactivity (Polga´r et al., 2013), and the co-release
of both transmitters at some mixed GABAergic/glycinergic syn-
apses has been demonstrated (Che´ry and De Koninck, 1999;
O’Brien and Berger, 1999). Surprisingly, we found that blocking
GABAergic transmission is sufficient to prevent the effects of
TAFA4, thereby suggesting the segregation of GABAergic and
glycinergic inhibitory pathways. In rat spinal cord, the co-release
of GABA and glycine was found to be pronounced during devel-
opment and to have ceased by adulthood (Keller et al., 2001).
This separation of GABAergic and glycinergic systems is in line
with findings from recent studies showing segregation of glyci-2894 Cell Reports 22, 2886–2897, March 13, 2018nergic and GABAergic inputs on dorsal
horn excitatory neurons, depending on
their dorso-ventral location (Takazawa
et al., 2017). Differences can also be
observed in the distribution of glycine and
GABA receptors (Harvey et al., 2004;
Todd et al., 1996), thus demonstrating
that GABAergic and glycinergic pathways
are functionally distinct in the spinal cord.
As mentioned earlier, our results,
together with the findings of Lu and Perl
(2005), suggest that C-LTMRs contact
islet cells. The latter are all GABAergic,
and only some of them seem to co-ex-
press glycine (Spike and Todd, 1992). Inaddition, Lu and Perl (2005) demonstrated that the synapse be-
tween islet cells and central cells is blocked by GABAA antag-
onists, which reinforces our finding that the effects of TAFA4
are mediated mainly by GABAergic transmission.
We did not challenge the respective role of GABAA versus
GABAB receptors in mediating the effects of TAFA4. Our previ-
ous findings (Delfini et al., 2013) identified potassium channels
as putative targets for TAFA4. As potassium channels may be
highly modulated by GABAB receptors, one could postulate
that, in addition to GABAA receptors, GABAB receptors may
also partly mediate the effects of TAFA4. Thus, by restoring
GABAergic inhibition, TAFA4 could alter the intrinsic properties
and the excitability of spinal interneurons through yet-uniden-
tified signaling cascades. An action mediated by GABAB
receptors involving the recruitment of signaling cascades and
long-term cell plasticity could also partly explain why we rarely
observed a recovery upon TAFA4 washout.
Microglia Are Required for the Effects of TAFA4
Microglia are known to regulate the efficacy of synaptic trans-
mission and, specifically, inhibitory transmission in pathological
pain conditions (Ji et al., 2013) through a wide range of mecha-
nisms. For instance, in neuropathic pain models, brain-derived
neurotrophic factor (BDNF) released by microglial cells within
the spinal cord induces an inversion of the polarity of GABA-
mediated currents and contributes to tactile allodynia after nerve
injury (Coull et al., 2005). Moreover, proinflammatory cytokines
such as interleukin-1b, interleukin-6, and tumor necrosis fac-
tor-a are involved in central sensitization by increasing excitatory
synaptic transmission or reducing inhibitory synaptic transmis-
sion (Clark et al., 2015; Kawasaki et al., 2008). In inflammatory
pain models, some studies have reported a lack of spinal micro-
glial activation when CFA is injected in the rear paw (Lin et al.,
2007; Sun et al., 2007), while others have reported clear indica-
tors of microglial activation following CFA hindpaw inflammation
(Hui et al., 2013; Liao et al., 2017; Qi et al., 2016; Raghavendra
et al., 2004; Xu et al., 2014). We found that CFA induced a major
increase in the surface immunostained by Iba1 within lamina II of
the spinal cord. Surprisingly, intrathecal injection of TAFA4
reduced the Iba1-labeled area in CFA animals, suggesting that
TAFA4 exerts its antinociceptive action by triggering a reduction
in microglial activation.
Our finding that TAFA4 acts through microglia is further rein-
forced by the recent identification of a putative receptor of
TAFA4, the FPR1 (Wang et al., 2015), which is located on cells
deriving from myeloid lineage (Dorward et al., 2015; Gavins,
2010). Surprisingly, however, in most studies (Dorward et al.,
2015; Hauser et al., 2010; Raoof et al., 2010; Wang et al.,
2015), activation of FRP1 is believed to promote macrophage
activation, macrophage phagocytosis, and the production of
reactive oxygen species. In our experiments, we found that
TAFA4 rather promotes a decrease in the surface occupied by
microglia in lamina II, suggesting a reduction in microglial activa-
tion. Several factors may account for this paradoxical effect.
First, the effects of TAFA4 on macrophage activation are known
to be highly dependent upon its concentration (Wang et al.,
2015). Second, discrepancies in the reaction of macrophages
andmicroglia to a given stimulusmay often be observed (Hooper
et al., 2009; Durafourt et al., 2012).
Displacing Inhibitory Synapses with Microglia?
Disruption of GABAergic transmission is a well-known phenom-
enon in pathological pain. However, the mechanisms involved in
this disinhibition are still a matter of debate. In neuropathic pain
models, a loss of GABAergic neurons (Todd, 2015; Taylor, 2009),
a downregulation of the GABA synthesis enzyme (Moore et al.,
2002), or a decrease in synaptic strength due to a shift in chloride
reversal potential (Coull et al., 2005) have been proposed to
contribute to this disinhibition. Although some of these mecha-
nisms may exist in inflammatory pain models (Zhang et al.,
2013), much less is known about GABAergic disinhibition in
them. Several studies have reported a direct effect of inflamma-
tory mediators on glycinergic transmission (Ahmadi et al., 2002;
Kawasaki et al., 2008). This reduction in glycinergic inhibitory
transmission may be accompanied by a shift in inhibitory
transmission toward GABAergic transmission. Our immunocyto-
chemical analysis highly suggests that, in addition to these
mechanisms, CFA inflammation induces a decrease in the den-
sity of inhibitory synapses on lamina IIi somata that is reversed byintrathecal injection of TAFA4. Interestingly, no change in the
excitatory synapse marker Homer was observed, highlighting
the specificity of this mechanism to inhibitory inputs. Given
that, in our experimental conditions, the density of inhibitory syn-
apses mirrored the extension of microglial cells, it is tempting to
speculate that the extension of microglial cells in CFA-inflamed
animals induces a displacement of inhibitory synapses (synaptic
stripping) and that TAFA4 enables the restoration of these inhib-
itory synapses in lamina IIi by reducingmicroglial spreading, thus
reinforcing inhibitory tonus and providing anti-nociception. Syn-
aptic stripping was first identified in a facial nerve injury model by
Blinzinger and Kreutzberg (1968) before the phenomenon was
generalized to other structures and pathological models (Chen
et al., 2014; Trapp et al., 2007). Although the release of pro-in-
flammatory substances may also be involved in the regulation
of inhibitory transmission by microglia under the control of
TAFA4 (Ahmadi et al., 2002; Kawasaki et al., 2008), our data
highlight a central mechanism in the regulation of pain transmis-
sion by microglial cells.
EXPERIMENTAL PROCEDURES
Detailed procedures are available in the Supplemental Experimental
Procedures.
Animals
Protocols were approved by the local ethics committee (ref. 50120155A).
C57BL/6J and TAFA4Venus+/ mice were maintained under standard housing
conditions (22C, 40% humidity, 12-hr/12-hr light-dark cycle, and unlimited
access to food and water). Experiments were performed on male animals
except for in vitro electrophysiology, where both male and females were used.
In Vitro Electrophysiology
Patch-clamp recordings were performed at 31C on 300-mm spinal slices of
young animals (postnatal day [P]17–P30) in warm aCSF (31C) under infrared
visual control, using KGlu-based (for EPSCs) or KCl-based (for IPSCs) internal
solutions. Spontaneous and miniature synaptic events were analyzed using
spike2 and visually filtered blind to experimental conditions.
In Vivo Electrophysiology
T13 and L1 vertebrae and dura mater were removed from deeply anesthetized
mice (isoflurane, 2.5%), and superficial dorsal horn neurons were recorded
with a glass electrode while stimulating the right hindpaw with Von Frey hairs.
Drugs were injected through a second glass pipette inserted in the vicinity of
the recording site.
Behavioral Assays
Mechanical allodynia and hyperalgesiawere assessed on8-week-old littermate
maleswithVonFreyhairs using the ‘‘up anddownmethod.’’ Intrathecal injection
of recombinant TAFA4, CGP, and phaclofen was performed in awake animals.
Electron Microscopy
Adult TAFA4Venus+/ heterozygousmicewere fixed with 4%paraformaldehyde
and 0.5% glutaraldehyde. Sections were single, double, and/or triple stained
following a conventional post-embedding protocol with antibodies raised
against GABA, Venus, and VGlut3 and observed on a JEM-1010 transmission
electron microscope.
Tissue Sections and Immunofluorescence
Immunofluorescence experiments were carried out using standard protocols.
Images were acquired on an SPE Leica confocal microscope and analyzed
with ImageJ. Sample preparation, acquisition, and analysis were performed
blind to the experimental conditions.Cell Reports 22, 2886–2897, March 13, 2018 2895
Statistics
Datasets were compared using either the Kolmogorov Smirnov test, Student’s
paired t test, or its non-parametric counterpart (Wilcoxon signed-rank test).
When comparing more than two datasets, ANOVA (one-way, two-way, or
repeated-measures) was used (see figure legends). p < 0.05 was considered
as statistically different.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2018.02.068.
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